Increased risk of squamous cell esophageal cancer after adjuvant radiation therapy for primary breast cancer

American Journal of Epidemiology

Volumn 161, Issue 4, 2005, Pages 330-337

  Zablotska, Lydia B ^a   Chak, Amitabh ^b   Das, Ananya ^b   Neugut, Alfred I ^a,c  

^a Columbia University ^*  (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Mailman School of Public Health ^*  (United States)

Author keywords

Breast neoplasms; Esophageal neoplasms; Mastectomy; Mastectomy, segmental; Neoplasms, second primary; Radiotherapy; Registries

Indexed keywords

CANCER; RISK FACTOR; WOMENS HEALTH;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; PARTIAL MASTECTOMY; RADIATION HAZARD; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; TUMOR LOCALIZATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; NEOPLASMS, SQUAMOUS CELL; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; SEER PROGRAM;

EID: 13844275245     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwi050     Document Type: Article

References (39)

1. Ribeiro U Jr, Posner MC, Safatle-Ribeiro AV, et al. Risk factors for squamous cell carcinoma of the oesophagus. Br J Surg 1996;83:1174-85.
2. Daly JM, Karnell LH, Menck HR. National Cancer Data Base report on esophageal carcinoma. Cancer 1996;78:1820-8.
3. Parker RG, Enstrom JE. Second primary cancers of the head and neck following treatment of initial primary head and neck cancers. Int J Radiat Oncol Biol Phys 1988;14:561-4.
4. Seydel HG. The risk of tumor induction in man following medical irradiation for malignant neoplasm. Cancer 1975;35:1641-5.
5. Goffman TE, McKeen EA, Curtis RE, et al. Esophageal carcinoma following irradiation for breast cancer. Cancer 1983;52: 1808-9.
6. Scholl B, Reis ED, Zouhair A, et al. Esophageal cancer as second primary tumor after breast cancer radiotherapy. Am J Surg 2001;182:476-80.
7. Micke O, Schafer U, Glashorster M, et al. Radiation-induced esophageal carcinoma 30 years after mediastinal irradiation: case report and review of the literature. Jpn J Clin Oncol 1999; 29:164-70.
8. Weiss HA, Darby SC, Doll R. Cancer mortality following x-ray treatment for ankylosing spondylitis. Int J Cancer 1994;59: 327-38.
9. Griem ML, Kleinerman RA, Boice JD Jr, et al. Cancer following radiotherapy for peptic ulcer. J Natl Cancer Inst 1994;86: 842-9.
10. Carr ZA, Kleinerman RA, Stovall M, et al. Malignant neoplasms after radiation therapy for peptic ulcer. Radiat Res 2002; 157:668-77.
11. Boice JD Jr, Preston D, Davis FG, et al. Frequent chest X-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts. Radiat Res 1991;125:214-22.
12. Davis FG, Boice JD Jr, Hrubec Z, et al. Cancer mortality in a radiation-exposed cohort of Massachusetts tuberculosis patients. Cancer Res 1989;49:6130-6.
13. Little MP, Boice JD Jr. Comparison of breast cancer incidence in the Massachusetts tuberculosis fluoroscopy cohort and in the Japanese atomic bomb survivors. Radiat Res 1999;151:218-24.
14. Curtis RE, Boice JD Jr, Stovall M, et al. Leukemia risk following radiotherapy for breast cancer. J Clin Oncol 1989;7:21-9.
15. Lichter AS, Lippman ME, Danforth DN Jr, et al. Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute. J Clin Oncol 1992;10:976-83.
16. Fisher B, Anderson S, Redmond CK, et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995;333:1456-61.
17. Boice JD Jr, Harvey EB, Blettner M, et al. Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med 1992;326:781-5.
18. Preston DL, Shimizu Y, Pierce DA, et al. Studies of mortality of atomic bomb survivors. Report 13: solid cancer and noncancer disease mortality: 1950-1997. Radiat Res 2003;160:381-407.
19. Ahsan H, Neugut AI. Radiation therapy for breast cancer and increased risk for esophageal carcinoma. Ann Intern Med 1998; 128:114-17.
20. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) public-use data (1973-2000), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2003, based on the August 2002 submission.
21. Brenner DJ, Schiff PB, Zablotska LB. Adjuvant radiotherapy for DCIS. (Letter). Lancet 2000;355:2071; author reply 2072-3.
22. World Health Organization. International classification of diseases. Manual of the international statistical classification of diseases, injuries, and causes of death. Ninth Revision. Geneva, Switzerland: World Health Organization, 1977.
23. Percy C, Van Holten V, Muir CS, eds. International classification of diseases for oncology. 2nd ed. Geneva, Switzerland: World Health Organization, 1990.
24. Allison PD. Survival analysis using the SAS system: a practical guide. Cary, NC: SAS Institute, Inc, 1995.
25. Pierce DA, Shimizu Y, Preston DL, et al. Studies of the mortality of atomic bomb survivors. Report 12, part I. Cancer: 1950-1990. Radiat Res 1996;146:1-27.
26. Thompson DE, Mabuchi K, Ron E, et al. Cancer incidence in atomic bomb survivors. Part II: solid tumors, 1958-1987. Radiat Res 1994;137:S17-67.
27. Boice JD Jr, Day NE, Andersen A, et al. Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J Natl Cancer Inst 1985; 74:955-75.
28. Kleinerman RA, Boice JD Jr, Storm HH, et al. Second primary cancer after treatment for cervical cancer. An international cancer registries study. Cancer 1995;76:442-52.
29. Little MP. Cancer after exposure to radiation in the course of treatment for benign and malignant disease. Lancet Oncol 2001;2:212-20.
30. Inskip PD, Stovall M, Flannery JT. Lung cancer risk and radiation dose among women treated for breast cancer. J Natl Cancer Inst 1994;86:983-8.
31. Das IJ, Cheng CW, Fein DA, et al. Patterns of dose variability in radiation prescription of breast cancer. Radiother Oncol 1997;44:83-9.
32. Vicini FA, Chen PY, Fraile M, et al. Low-dose-rate brachytherapy as the sole radiation modality in the management of patients with early-stage breast cancer treated with breast-conserving therapy: preliminary results of a pilot trial. Int J Radiat Oncol Biol Phys 1997;38:301-10.
33. Vicini F, Kini VR, Chen P, et al. Irradiation of the tumor bed alone after lumpectomy in selected patients with early-stage breast cancer treated with breast conserving therapy. J Surg Oncol 1999;70:33-40.
34. Inskip PD, Boice JD Jr. Radiotherapy-induced lung cancer among women who smoke. Cancer 1994;73:1541-3.
35. Neugut AI, Meadows AT, Robinson E. Multiple primary cancers. Philadelphia, PA: Lippincott Williams & Wilkins, 1999: 484.
36. Travis LB, Curtis RE, Inskip PD, et al. Re: Lung cancer risk and radiation dose among women treated for breast cancer. (Letter). J Natl Cancer Inst 1995;87:60-1.
37. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997;337: 949-55.
38. Ahsan H, Neugut AI, Gammon MD. Association of adenocarcinoma and squamous cell carcinoma of the esophagus with tobacco-related and other malignancies. Cancer Epidemiol Biomarkers Prev 1997;6:779-82.
39. Du X, Freeman JL, Goodwin JS. Information on radiation treatment in patients with breast cancer: the advantages of the linked Medicare and SEER data. Surveillance, Epidemiology and End Results. J Clin Epidemiol 1999;52:463-70.